All Imrul Shahriar articles
-
NewsTherapeutic proven to reduce advanced-stage influenza viral loads faster, more thoroughly in preclinical studies
Eradivir, a preclinical biotech company, has developed a patent-pending antiviral therapeutic that reduces lung viral loads of advanced-stage influenza in preclinical studies quicker and more effectively than currently available therapies.
